Discontinuation report INVIRASE - CAP 200MG
Report ID | 53093 |
Drug Identification Number | 02216965 |
Brand name | INVIRASE - CAP 200MG |
Common or Proper name | Saquinavir mesylate (Invirase) |
Company Name | HOFFMANN-LA ROCHE LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SAQUINAVIR |
Strength(s) | 200MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 270 pills/pack |
ATC code | J05AE |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-12-31 |
Actual discontinuation date | |
Remaining supply date | 2018-12-31 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2018-06-28 | French | Compare |
v2 | 2018-06-28 | English | Compare |
v1 | 2018-06-28 | English | Compare |
Showing 1 to 3 of 3